Article
A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumours
1 Jul 2025
Abstract excerpt
Targeted next generation sequencing (NGS) using multigene panels has become an effective tool for comprehensive genomic analysis in cancer, overcoming limitations of single gene assays. Nonetheless, outsourcing these assays to external laboratories and the extended turnaround time (~ 3 weeks) required for obtaining results may impede timely clinical management of cancer patients. We developed an oncopanel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
